BPP Leadership Team

Paul B. Dumond
Chief Executive Officer
Invention, Scientific Platform, IP, Patent, Payer Reimbursement
Study, Regulatory Pathway, Clinical Trial program and
Licensing Initiatives
Kim A. Heidenreich, PhD - Neuropharmacology
Chief Scientific Officer
Professor Emeritus, University of Colorado School of Medicine
Invention, Scientific Platform, IP, Regulatory Pathway,
Clinical Trial program initiatives
Douglas R. Stephan
President
Invention, Capital Program Interface, Regulatory Pathway,
Licensing Initiatives
David Brin
Member
Capital Interface and Management, Technical Support initiatives
Matt Veatch
Head of Programs
Former Strategic Operations VP, Syneos Health
Former Head of Real World Data-Driven Research, Quintiles
Pharma Interface, Regulatory Strategy and Pathway management,
Clinical Trial and Licensing initiatives
Jason Kralic, PhD - Neuropharmacology
Head of Business Development
Former Head of CNS Business Development, GlaxoSmithKline
Pharma Interface, Regulatory and Clinical Trial initiatives, Licensing